elhamkhani
/
Test2
/
Login
Register
TriplyDB
Test2
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
GraphQL
BETA
Graphs
1
Q52718168-BD19585D-676E-441F-A021-EC5D57806929
Q52718168-BD19585D-676E-441F-A021-EC5D57806929
BestRank
Statement
http://www.wikidata.org/entity/statement/Q52718168-BD19585D-676E-441F-A021-EC5D57806929
Aggressive natural killer-cell leukemia mutational landscape and drug profiling highlight JAK-STAT signaling as therapeutic target.
P2860
Q52718168-BD19585D-676E-441F-A021-EC5D57806929
BestRank
Statement
http://www.wikidata.org/entity/statement/Q52718168-BD19585D-676E-441F-A021-EC5D57806929
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
960892f6bfc361dc0b98705e6d5239bfe4cb46a1
P2860
Type II enteropathy-associated T-cell lymphoma features a unique genomic profile with highly recurrent SETD2 alterations.